Vaccine Scheduling Notice

The 2026/2027 COVID-19 vaccine is FDA approved for adults ages 65 years and older and for patients 6 months–64 years with certain health conditions that put them at high risk for severe outcomes from COVID-19 virus. Harmons currently offers COVID-19 vaccines starting at age 12 and other vaccines at age 5.

According to the CDC, age remains the strongest risk factor for severe COVID-19 outcomes, with risk of severe outcomes increasing markedly with increasing age. COVID-19 vaccination is recommended for all adults ages 65 years and older based on individual-based decision-making. For people ages 6 months–64 years, vaccination is recommended based on individual-based decision-making—with an emphasis that the risk-benefit of vaccination is most favorable for individuals who are at an increased risk for severe COVID-19 disease, according to the CDC list of COVID-19 risk factors.

For more information if you are eligible for the COVID-19 vaccine please click this link.